Literature DB >> 18606676

Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells.

Phillip H Horne1, Jason M Zimmerer, Mason G Fisher, Keri E Lunsford, Gyongyi Nadasdy, Tibor Nadasdy, Nico van Rooijen, Ginny L Bumgardner.   

Abstract

Despite the recognition that humoral rejection is an important cause of allograft injury, the mechanism of Ab-mediated injury to allograft parenchyma is not well understood. We used a well-characterized murine hepatocellular allograft model to determine the mechanism of Ab-mediated destruction of transplanted liver parenchymal cells. In this model, allogeneic hepatocytes are transplanted into CD8-deficient hosts to focus on CD4-dependent, alloantibody-mediated rejection. Host serum alloantibody levels correlated with in vivo allospecific cytotoxic activity in CD8 knockout hepatocyte rejector mice. Host macrophage depletion, but not CD4(+) T cell, NK cell, neutrophil, or complement depletion, inhibited in vivo allocytotoxicity. Recipient macrophage deficiency delayed CD4-dependent hepatocyte rejection and inhibited in vivo allocytotoxicity without influencing alloantibody production. Furthermore, hepatocyte coincubation with alloantibody and macrophages resulted in Ab-dependent hepatocellular cytotoxicity in vitro. These studies are consistent with a paradigm of acute humoral rejection in which CD4(+) T cell-dependent alloantibody production results in the targeting of transplanted allogeneic parenchymal cells for macrophage-mediated cytotoxic immune damage. Consequently, strategies to eliminate recipient macrophages during CD4-dependent rejection pathway may prolong allograft survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606676      PMCID: PMC3022512          DOI: 10.4049/jimmunol.181.2.1224

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction.

Authors:  Alin L Girnita; Rene Duquesnoy; Samuel A Yousem; Aldo T Iacono; Timothy E Corcoran; Manuela Buzoianu; Bruce Johnson; Kathy J Spichty; James H Dauber; Gilbert Burckart; Bartley P Griffith; Kenneth R McCurry; Adriana Zeevi
Journal:  Am J Transplant       Date:  2005-01       Impact factor: 8.086

2.  Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver.

Authors:  M Tomita; K Yamamoto; H Kobashi; M Ohmoto; T Tsuji
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

3.  Lobular damage caused by cellular and humoral immunity in liver allograft rejection.

Authors:  Tokihiko Sawada; Akira Shimizu; Keiichi Kubota; Shohei Fuchinoue; Satoshi Teraoka
Journal:  Clin Transplant       Date:  2005-02       Impact factor: 2.863

4.  A comparison of hepatic, splenic, peritoneal and alveolar macrophages with respect to PGE2, TXB2, production and ADCC function.

Authors:  J Z Wu; C K Ogle; J D Ogle; J W Alexander
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1993-02       Impact factor: 4.006

5.  A functional model of hepatocyte transplantation for in vivo immunologic studies.

Authors:  G L Bumgardner; M Heininger; J Li; D Xia; J Parker-Thornburg; R M Ferguson; C G Orosz
Journal:  Transplantation       Date:  1998-01-15       Impact factor: 4.939

6.  Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema.

Authors:  K Trpkov; P Campbell; F Pazderka; S Cockfield; K Solez; P F Halloran
Journal:  Transplantation       Date:  1996-06-15       Impact factor: 4.939

7.  C6 produced by macrophages contributes to cardiac allograft rejection.

Authors:  Z Qian; B A Wasowska; E Behrens; D L Cangello; J R Brody; S S Kadkol; L Horwitz; J Liu; C Lowenstein; A D Hess; F Sanfilippo; W M Baldwin
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

8.  Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.

Authors:  Z Qian; F M Jakobs; T Pfaff-Amesse; F Sanfilippo; W M Baldwin
Journal:  J Heart Lung Transplant       Date:  1998-05       Impact factor: 10.247

9.  Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients.

Authors:  M A Lones; L S Czer; A Trento; D Harasty; J M Miller; M C Fishbein
Journal:  J Heart Lung Transplant       Date:  1995 Jan-Feb       Impact factor: 10.247

10.  Activation of intravascular macrophages within myocardial small vessels is a feature of acute vascular rejection in human heart transplants.

Authors:  N B Ratliff; J T McMahon
Journal:  J Heart Lung Transplant       Date:  1995 Mar-Apr       Impact factor: 10.247

View more
  14 in total

1.  Critical Role of Macrophage FcγR Signaling and Reactive Oxygen Species in Alloantibody-Mediated Hepatocyte Rejection.

Authors:  Jason M Zimmerer; Xin L Liu; Alecia Blaszczak; Christina L Avila; Thomas A Pham; Robert T Warren; Ginny L Bumgardner
Journal:  J Immunol       Date:  2018-11-05       Impact factor: 5.422

Review 2.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

Review 3.  Immunological aspects of liver cell transplantation.

Authors:  Felix Oldhafer; Michael Bock; Christine S Falk; Florian W R Vondran
Journal:  World J Transplant       Date:  2016-03-24

4.  Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.

Authors:  Dilip S Nath; Haseeb Ilias Basha; Venkataswarup Tiriveedhi; Chiraag Alur; Donna Phelan; Gregory A Ewald; Nader Moazami; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2010-07-07       Impact factor: 10.247

5.  CD8+ T cells negatively regulate IL-4-dependent, IgG1-dominant posttransplant alloantibody production.

Authors:  Jason M Zimmerer; Thomas A Pham; Virginia M Sanders; Ginny L Bumgardner
Journal:  J Immunol       Date:  2010-11-17       Impact factor: 5.422

6.  Cytotoxic effector function of CD4-independent, CD8(+) T cells is mediated by TNF-α/TNFR.

Authors:  Jason M Zimmerer; Phillip H Horne; Lori A Fiessinger; Mason G Fisher; Thomas A Pham; Samiya L Saklayen; Ginny L Bumgardner
Journal:  Transplantation       Date:  2012-12-15       Impact factor: 4.939

7.  Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipients.

Authors:  Jason M Zimmerer; Phillip H Horne; Lori A Fiessinger; Mason G Fisher; Kartika Jayashankar; Sierra F Garcia; Mahmoud Abdel-Rasoul; Nico van Rooijen; Ginny L Bumgardner
Journal:  Cell Transplant       Date:  2012-10-11       Impact factor: 4.064

8.  Comparison of immunopathology and locomotor recovery in C57BL/6, BUB/BnJ, and NOD-SCID mice after contusion spinal cord injury.

Authors:  Sabina Luchetti; Kevin D Beck; Manuel D Galvan; Richard Silva; Brian J Cummings; Aileen J Anderson
Journal:  J Neurotrauma       Date:  2010-02       Impact factor: 5.269

9.  Antibody-suppressor CD8+ T Cells Require CXCR5.

Authors:  Jason M Zimmerer; Bryce A Ringwald; Steven M Elzein; Christina L Avila; Robert T Warren; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  Transplantation       Date:  2019-09       Impact factor: 4.939

10.  mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.

Authors:  Christina L Avila; Jason M Zimmerer; Steven M Elzein; Thomas A Pham; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  Transplantation       Date:  2016-09       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.